140 related articles for article (PubMed ID: 38876051)
1. The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma.
Guo S; Wang X; Wang Y; Bai J; Liu Y; Shao Z
Biomed Pharmacother; 2024 Jul; 176():116906. PubMed ID: 38876051
[TBL] [Abstract][Full Text] [Related]
2. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
[TBL] [Abstract][Full Text] [Related]
3. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
4. The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma.
Wang X; Guo J; Yu P; Guo L; Mao X; Wang J; Miao S; Sun J
J Exp Clin Cancer Res; 2021 Jan; 40(1):35. PubMed ID: 33478586
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms.
Wang G; Zhang M; Cheng M; Wang X; Li K; Chen J; Chen Z; Chen S; Chen J; Xiong G; Xu X; Wang C; Chen D
Cancer Lett; 2021 Jun; 507():55-69. PubMed ID: 33741424
[TBL] [Abstract][Full Text] [Related]
6. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.
Song A; Wu L; Zhang BX; Yang QC; Liu YT; Li H; Mao L; Xiong D; Yu HJ; Sun ZJ
Cancer Lett; 2024 Apr; 588():216727. PubMed ID: 38431035
[TBL] [Abstract][Full Text] [Related]
7. Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck.
Zandberg DP; Menk AV; Velez M; Normolle D; DePeaux K; Liu A; Ferris RL; Delgoffe GM
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986123
[TBL] [Abstract][Full Text] [Related]
8. Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma.
Domingo-Vidal M; Whitaker-Menezes D; Martos-Rus C; Tassone P; Snyder CM; Tuluc M; Philp N; Curry J; Martinez-Outschoorn U
Mol Cancer Res; 2019 Sep; 17(9):1893-1909. PubMed ID: 31239287
[TBL] [Abstract][Full Text] [Related]
9. Targeting cellular metabolism to reduce head and neck cancer growth.
Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X
Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051
[TBL] [Abstract][Full Text] [Related]
10. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
J Hematol Oncol; 2019 Dec; 12(1):132. PubMed ID: 31805962
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
Masamha CP; LaFontaine P
J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
[TBL] [Abstract][Full Text] [Related]
12. Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib.
Hu F; Guo L; Yu J; Dai D; Xiong Y; He Y; Zhou W
Pathol Oncol Res; 2021; 27():1610008. PubMed ID: 34955687
[No Abstract] [Full Text] [Related]
13. Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma.
Madhukar G; Subbarao N
Curr Cancer Drug Targets; 2021; 21(5):386-400. PubMed ID: 33372876
[TBL] [Abstract][Full Text] [Related]
14. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.
Gorur A; Patiño M; Shi T; Corrales G; Takahashi H; Rangel R; Gleber-Netto FO; Pickering C; Myers JN; Cata JP
J Cell Physiol; 2021 Nov; 236(11):7698-7710. PubMed ID: 34038587
[TBL] [Abstract][Full Text] [Related]
15. Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase.
Kamarajan P; Rajendiran TM; Kinchen J; Bermúdez M; Danciu T; Kapila YL
J Proteome Res; 2017 Mar; 16(3):1315-1326. PubMed ID: 28168879
[TBL] [Abstract][Full Text] [Related]
16. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS
Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.
Zhao C; Zhou X; Cao Z; Ye L; Cao Y; Pan J
Phytomedicine; 2023 Oct; 119():154986. PubMed ID: 37506572
[TBL] [Abstract][Full Text] [Related]
18. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
19. Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
Ye G; Zhang J; Zhang C
Aging (Albany NY); 2021 Aug; 13(16):20793-20807. PubMed ID: 34459788
[TBL] [Abstract][Full Text] [Related]
20. Cell death in head and neck cancer pathogenesis and treatment.
Raudenská M; Balvan J; Masařík M
Cell Death Dis; 2021 Feb; 12(2):192. PubMed ID: 33602906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]